179 related articles for article (PubMed ID: 15154309)
1. [Prophylactic platelet transfusion in patients with hematologic diseases].
Siitonen T; Koistinen P
Duodecim; 2004; 120(7):877-84. PubMed ID: 15154309
[No Abstract] [Full Text] [Related]
2. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
Stanworth SJ; Hyde C; Brunskill S; Murphy MF
Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusions for patients with haematological malignancies: who needs them?
Estcourt LJ; Stanworth SJ; Murphy MF
Br J Haematol; 2011 Aug; 154(4):425-40. PubMed ID: 21615375
[TBL] [Abstract][Full Text] [Related]
4. [Immunological aspects of blood transfusion preparations].
Matinlauri I
Duodecim; 2004; 120(7):867-75. PubMed ID: 15154308
[No Abstract] [Full Text] [Related]
5. Platelet transfusion therapy.
Slichter SJ
Hematol Oncol Clin North Am; 2007 Aug; 21(4):697-729, vii. PubMed ID: 17666286
[TBL] [Abstract][Full Text] [Related]
6. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
[TBL] [Abstract][Full Text] [Related]
7. Novel methodology for assessment of prophylactic platelet transfusion therapy by measuring increased thrombus formation and thrombin generation.
Cauwenberghs S; Feijge MA; Theunissen E; Heemskerk JW; van Pampus EC; Curvers J
Br J Haematol; 2007 Feb; 136(3):480-90. PubMed ID: 17176266
[TBL] [Abstract][Full Text] [Related]
8. Real-time ultrasound-guided central venous catheterization reduces the need for prophylactic platelet transfusion in thrombocytopenic patients with hematological malignancy.
Tomoyose T; Ohama M; Yamanoha A; Masuzaki H; Okudaira T; Tokumine J
Transfus Apher Sci; 2013 Oct; 49(2):367-9. PubMed ID: 23083962
[No Abstract] [Full Text] [Related]
9. [Platelet and granulocyte transfusion in hematology].
Ouellet P
Union Med Can; 1983 May; 112(5):457-60. PubMed ID: 6879858
[No Abstract] [Full Text] [Related]
10. Transfusion of apheresis platelets and ABO groups.
Vox Sang; 2005 Apr; 88(3):207-21. PubMed ID: 15787735
[No Abstract] [Full Text] [Related]
11. Compliance with prophylactic platelet transfusion trigger in haematological patients.
Eikenboom JC; van Wordragen R; Brand A
Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
[TBL] [Abstract][Full Text] [Related]
12. [Transfusion of platelet concentrates].
Bierling P
Transfus Clin Biol; 2009 May; 16(2):190-4. PubMed ID: 19443251
[TBL] [Abstract][Full Text] [Related]
13. Alloimmunization and platelet transfusion.
McFarland JG
Semin Hematol; 1996 Oct; 33(4):315-28. PubMed ID: 8916305
[No Abstract] [Full Text] [Related]
14. Fetal bradycardia following intrauterine platelet transfusion: might elevated levels of donor soluble CD40 ligand play a role?
Yazicioglu HF; Hartwig D; von Witzleben-Schürholz E; Neppert J; Gembruch U
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):868-9. PubMed ID: 15315602
[No Abstract] [Full Text] [Related]
15. Platelet transfusion strategy for hematologic cancers.
Podda GM; Ricci S
Intern Emerg Med; 2015 Feb; 10(1):81-2. PubMed ID: 25358897
[No Abstract] [Full Text] [Related]
16. Strategies for managing refractoriness to platelet transfusions.
Dan ME; Schiffer CA
Curr Hematol Rep; 2003 Mar; 2(2):158-64. PubMed ID: 12901147
[TBL] [Abstract][Full Text] [Related]
17. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy.
Josephson CD; Mullis NC; Van Demark C; Hillyer CD
Transfusion; 2004 Jun; 44(6):805-8. PubMed ID: 15157243
[TBL] [Abstract][Full Text] [Related]
18. [Special features of blood transfusions to hematologic patients].
Oksanen K
Duodecim; 1998; 114(12):1233-9. PubMed ID: 11524769
[No Abstract] [Full Text] [Related]
19. PLT transfusions from D+ blood donors to D-patients with hematologic diseases: am update.
Cid J
Transfusion; 2003 Dec; 43(12):1759-60. PubMed ID: 14674374
[No Abstract] [Full Text] [Related]
20. Blood transfusions in children with cancer and hematologic disorders: why, when, and how?
Buchanan GR
Pediatr Blood Cancer; 2005 Feb; 44(2):114-6. PubMed ID: 15578665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
